Fundraising Fox
Cardurion Pharmaceuticals
Burlington, US · Founded 2017 · 74 employees on LinkedIn · 12 known investors
Find your way into Cardurion Pharmaceuticals
Sign up to see every warm intro you have to Cardurion Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardurion Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization. It draws on a board of cardiovascular disease experts and industry veterans to guide its drug development.
Founders & leadership
Cardurion Pharmaceuticals was founded in 2017 by Michael E. Mendelsohn.
Investors · 12
How we know: the company's own site · funding news · Not right? Tell us
How we know: finance.yahoo.com · funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: Digitalis Ventures's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
How we know: finance.yahoo.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: finance.yahoo.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$260M disclosed across 1 of 2 rounds · 2024
- $260MSeries BJul 2024 · 3 sources
Ascenta Capital (lead), Bain, Bain Capital Life Sciences, GV, NEA
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cardurion Pharmaceuticals do?
- Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization. It draws on a board of cardiovascular disease experts and industry veterans to guide its drug development.
- Who founded Cardurion Pharmaceuticals?
- Cardurion Pharmaceuticals was founded by Michael E. Mendelsohn in 2017.
- Who are Cardurion Pharmaceuticals's investors?
- Cardurion Pharmaceuticals's investors include Bain Capital, Ascenta Capital, Delos Capital, Digitalis Ventures, New Enterprise Associates (NEA), Bain Capital Life Sciences, Bain Capital Tech Opportunities, Fidelity Investments and 3 more.
- How much funding has Cardurion Pharmaceuticals raised?
- Cardurion Pharmaceuticals has disclosed $260M raised across 1 of its 2 known rounds.
- Where is Cardurion Pharmaceuticals headquartered?
- Cardurion Pharmaceuticals is headquartered in Burlington, US.